82 FR 14901 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 55 (March 23, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 55 (March 23, 2017)
| Page Range | 14901-14901 | |
| FR Document | 2017-05733 |
[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)] [Notices] [Page 14901] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-05733] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcement (FOA) GH14-002, Addressing Emerging Infectious Diseases in Bangladesh; and FOA GH16-003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH). SUMMARY: This publication corrects a notice that was published in the Federal Register on March 9, 2017 Volume 82, Number 45, page 13119. The meeting announcement and matters for discussion should read as follows: The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcements (FOA) GH13-001, Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region; FOA GH14-002, Addressing Emerging Infectious Diseases in Bangladesh; and FOA GH16-003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH). Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region'', FOA GH13- 001; ``Addressing Emerging Infectious Diseases in Bangladesh'', FOA GH14-002; and ``Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH)'', FOA GH16-003. FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: (404) 639-4796, [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-05733 Filed 3-22-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices 14901
significant current potential threat to nomination period. Nominations collaboration with the Ministry of
human health. The availability of the received after the closing date will be Public Health in the Kingdom of
revised list of the 275 SPL substances marked as late and may be considered Thailand (MOPH)’’, FOA GH16–003.
was announced in April, 2015 on the only if time and resources permit. FOR FURTHER INFORMATION CONTACT:
following Web site: https:// Hylan Shoob, Scientific Review Officer,
Pamela I. Protzel Berman,
www.atsdr.cdc.gov/spl. Center for Global Health (CGH) Science
Associate Director, Office of Policy, Planning
Substances To Be Evaluated for Set 31 and Evaluation, National Center for Office, CGH, CDC, 1600 Clifton Road
Toxicological Profiles Environmental Health, Agency for Toxic NE., Mailstop D–69, Atlanta, Georgia
substances and Disease Registry. 30033, Telephone: (404) 639–4796,
Each year, ATSDR develops a list of HMS4@CDC.GOV.
substances to be considered for [FR Doc. 2017–05736 Filed 3–22–17; 8:45 am]
The Director, Management Analysis
toxicological profile development. The BILLING CODE 4163–70–P
and Services Office, has been delegated
Set 31 nomination process includes the authority to sign Federal Register
consideration of all substances on notices pertaining to announcements of
ATSDR’s SPL, as well as other DEPARTMENT OF HEALTH AND
HUMAN SERVICES meetings and other committee
substances nominated by the public. management activities, for both the
The 275 substances on the SPL will be Centers for Disease Control and Centers for Disease Control and
considered for Set 31 Toxicological Prevention and the Agency for Toxic
Prevention
Profile development. This list may be Substances and Disease Registry.
found at the following Web site: https:// Disease, Disability, and Injury
www.atsdr.cdc.gov/spl. Prevention and Control Special Claudette Grant,
Emphasis Panel (SEP): Initial Review Acting Director, Management Analysis and
Submission of Nominations for the
Services Office, Centers for Disease Control
Evaluation of Set 31 Proposed The meeting announced below and Prevention.
Substances concerns the Centers for Disease Control [FR Doc. 2017–05733 Filed 3–22–17; 8:45 am]
ATSDR also will consider the and Prevention (CDC) initial review of BILLING CODE 4163–18–P
nomination of any substance that is not applications in response to Funding
on the SPL under the authority of the Opportunity Announcement (FOA)
Comprehensive, Environmental GH14–002, Addressing Emerging DEPARTMENT OF HEALTH AND
Response, Compensation, and Liability Infectious Diseases in Bangladesh; and HUMAN SERVICES
Act (CERCLA) to ‘‘. . . establish and FOA GH16–003, Conducting Public
maintain an inventory of literature, Health Research in Thailand: Technical Centers for Disease Control and
research, and studies on the health collaboration with the Ministry of Prevention
effects of toxic substances’’ under Public Health in the Kingdom of
CERCLA Section 104(i)(1)(B), to respond Thailand (MOPH). Clinical Laboratory Improvement
to requests for consultation under SUMMARY: This publication corrects a Advisory Committee (CLIAC)
section 104(i)(4), and to support the site- notice that was published in the Federal Notice of Cancellation: This notice
specific response actions conducted by Register on March 9, 2017 Volume 82, was published in the Federal Register
ATSDR, as otherwise necessary. Number 45, page 13119. The meeting on March 9, 2017, Volume 82, Number
Today’s document invites voluntary announcement and matters for 45, page 13121. The meeting previously
public nominations for substances discussion should read as follows: scheduled to convene on April 12–13,
included on the SPL and for substances The meeting announced below 2017, has been canceled.
not listed on the SPL. All nominations concerns the Centers for Disease Control Contact Person for Additional
should include the full name of the and Prevention (CDC) initial review of Information: Nancy Anderson, Chief,
nominator, affiliation, and email applications in response to Funding Laboratory Practice Standards Branch,
address. When nominating a non-SPL Opportunity Announcements (FOA) Division of Laboratory Systems, Center
substance, please include the rationale GH13–001, Strengthening Disease for Surveillance, Epidemiology and
for the nomination. Please note that Prevention Research Capacity for Public Laboratory Services, Office of Public
email addresses will not be posted in Health Action in Guatemala and the Health Scientific Services, CDC, 1600
the docket found at Central American Region; FOA GH14– Clifton Road NE., Mailstop F–11,
www.regulations.gov. 002, Addressing Emerging Infectious Atlanta, Georgia 30329–4018; telephone
ATSDR will evaluate all data and Diseases in Bangladesh; and FOA (404) 498–2741; or via email at
information associated with nominated GH16–003, Conducting Public Health NAnderson@cdc.gov.
substances and will determine the final Research in Thailand: Technical The Director, Management Analysis
list of substances to be chosen for collaboration with the Ministry of and Services Office, has been delegated
toxicological profile development. Public Health in the Kingdom of the authority to sign Federal Register
Substances will be chosen according to Thailand (MOPH). notices pertaining to announcements of
ATSDR’s specific guidelines for Matters for Discussion: The meeting meetings and other committee
selection. These guidelines can be found will include the initial review, management activities for both the
in the Selection Criteria announced in discussion, and evaluation of Centers for Disease Control and
the Federal Register on May 7, 1993 (58 applications received in response to Prevention and the Agency for Toxic
‘‘Strengthening Disease Prevention
sradovich on DSK3GMQ082PROD with NOTICES
FR 27286). A hard copy of the Selection Substances and Disease Registry.
Criteria is available upon request or may Research Capacity for Public Health
be accessed at: http:// Action in Guatemala and the Central Claudette Grant,
www.atsdr.cdc.gov/toxprofiles/ American Region’’, FOA GH13–001; Acting Director, Management Analysis and
guidance/criteria_for_selecting_tp_ ‘‘Addressing Emerging Infectious Services Office, Centers for Disease Control
support.pdf. Diseases in Bangladesh’’, FOA GH14– and Prevention.
Please ensure that your comments are 002; and ‘‘Conducting Public Health [FR Doc. 2017–05731 Filed 3–22–17; 8:45 am]
submitted within the specified Research in Thailand: Technical BILLING CODE 4163–18–P
VerDate Sep<11>2014 17:13 Mar 22, 2017 Jkt 241001 PO 00000 Frm 00037 Fmt 4703 Sfmt 9990 E:\FR\FM\23MRN1.SGM 23MRN1](https://thefederalregister.org/doc/82_FR_14956/page/1.svg)
Document Created: 2017-03-23 02:45:42
Document Modified: 2017-03-23 02:45:42
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: (404) 639-4796, [email protected] | |
| FR Citation | 82 FR 14901 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR